Mind Medicine Inc., a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health ...

MindMed has announced the dosing of the first patient in its phase 3 Voyage study of MM120 ODT, a pharmaceutically optimised form of lysergide D-tartrate (LSD) for treating Generalised Anxiety ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

For the first time ever, researchers are administering LSD to patients in a Phase 3 clinical trial. The new study focuses on whether the psychedelic can be used to effectively treat generalized ...

Anxiety among teens, adolescents and young adults are on the rise, but there are ways to help manage and treat it.

Almost 1 in 5 adults in Austria is affected by at least one mental illness each year. The most common mental health issues ...

Other medication options for late-life GAD include ... Cognitive behavioural therapy is a gold standard treatment for anxiety disorders in younger patients, with proven efficacy in seniors in ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

Exposure and response prevention, often called ERP, is the gold standard treatment for OCD and will be a vital component of treatment. Below are several treatment options that we offer at our ...

Research indicates meditation techniques, particularly Transcendental Meditation, significantly alleviate PTSD symptoms, ...

Eating disorders are commonly associated with teenage girls. But the onset of perimenopause can be a trigger for some women ...